Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - ethinylestradiol, quantity: 30 microgram; levonorgestrel, quantity: 150 microgram - tablet, uncoated - excipient ingredients: lactose monohydrate; iron oxide yellow; brilliant blue fcf aluminium lake; polacrilin potassium; magnesium stearate - oral contraception

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

celgene pty ltd - ozanimod hydrochloride, quantity: 500 microgram (equivalent: ozanimod, qty 460 microgram) - capsule - excipient ingredients: gelatin; croscarmellose sodium; iron oxide black; magnesium stearate; microcrystalline cellulose; iron oxide red; iron oxide yellow; titanium dioxide; silicon dioxide; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide; ethanol absolute; ammonia - multiple sclerosis zeposia is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis.,ulcerative colitis zeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biological therapy.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - azelastine hydrochloride, quantity: 137 microgram/actuation (equivalent: azelastine, qty 125 microgram/actuation); fluticasone propionate, quantity: 50 microgram/actuation - spray, nasal - excipient ingredients: benzalkonium chloride; purified water; polysorbate 80; glycerol; disodium edetate; phenethyl alcohol; microcrystalline cellulose; carmellose sodium - symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 12 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - azelastine hydrochloride, quantity: 137 microgram/actuation (equivalent: azelastine, qty 125 microgram/actuation); fluticasone propionate, quantity: 50 microgram/actuation - spray, nasal - excipient ingredients: purified water; benzalkonium chloride; polysorbate 80; phenethyl alcohol; disodium edetate; glycerol; microcrystalline cellulose; carmellose sodium - symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 12 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - levonorgestrel, quantity: 30 microgram - tablet, sugar coated - excipient ingredients: lactose monohydrate; maize starch; povidone; purified talc; magnesium stearate; sucrose; macrogol 6000; calcium carbonate; glycol montanate - oral contraception

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

beauty ink 3 pty ltd - 61216 - electronic cosmetic micro-needling handpiece - a non-sterile, hand-held, device intended to be used in combination with a micro-needle cartridge (which contains micro-needles) to create high-density minute skin punctures to stimulate tissue regeneration and improve the appearance of the skin (i.e., to treat stretch marks, acne scarring, hyperpigmentation, wrinkles, hair loss) as part of collagen induction therapy (cit). it includes controls to allow for treatment adjustments (e.g., puncture depth, frequency); the micro-needles are not part of the handpiece, however a disposable micro-needle cartridge may be included. this is a reusable device

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

johel holdings pty ltd t/a alocuro - 61216 - electronic cosmetic micro-needling handpiece - a non-sterile, hand-held device intended to be used in combination with a micro-needle cartridge (which contains micro-needles) to create high-density minute skin punctures to stimulate tissue regeneration and improve the appearance of the skin (i.e., to treat stretch marks, acne scarring, hyperpigmentation, wrinkles, hair loss) as part of collagen induction therapy (cit). it includes controls to allow for treatment adjustments (e.g., puncture depth, frequency); the micro-needles are not part of the hand piece, however a disposable micro-needle cartridge may be included. this is a reusable device

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

orion pharma (aus) pty limited - dexmedetomidine hydrochloride, quantity: 472 microgram (equivalent: dexmedetomidine, qty 400 microgram) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation:,for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of dexdor by continuous infusion in these patients should not exceed 24 hours.,procedural sedation:,for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

orion pharma (aus) pty limited - dexmedetomidine hydrochloride, quantity: 236 microgram (equivalent: dexmedetomidine, qty 200 microgram) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation:,for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of dexdor by continuous infusion in these patients should not exceed 24 hours.,procedural sedation:,for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

orion pharma (aus) pty limited - dexmedetomidine hydrochloride, quantity: 1180 microgram (equivalent: dexmedetomidine, qty 1000 microgram) - injection, concentrated - excipient ingredients: water for injections; sodium chloride - intensive care unit (icu) sedation:,for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of dexdor by continuous infusion in these patients should not exceed 24 hours.,procedural sedation:,for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.